Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Achievement and SF3B1[original query] |
---|
The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy. Haematologica 2014 May 99 (5): 873-80. Santacruz Rodrigo, Villamor Neus, Aymerich Marta, Martínez-Trillos Alejandra, López Cristina, Navarro Alba, Rozman María, Beà Sílvia, Royo Cristina, Cazorla Maite, Colomer Dolors, Giné Eva, Pinyol Magda, Puente Xose S, López-Otín Carlos, Campo Elías, López-Guillermo Armando, Delgado Jul |
A randomized phase II trial of azacitidine +/- epoetin-ß in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents. Haematologica 2016 May . Thépot Sylvain, Ben Abdelali Raouf, Chevret Sylvie, Renneville Aline, Beyne-Rauzy Odile, Prébet Thomas, Park Sophie, Stamatoullas Aspasia, Guerci-Bresler Agnes, Cheze Stéphane, Tertian Gérard, Choufi Bachra, Legros Laurence, Bastié Jean Noel, Delaunay Jacques, Chaury Marie Pierre, Sanhes Laurence, Wattel Eric, Dreyfus Francois, Vey Norbert, Chermat Fatiha, Preudhomme Claude, Fenaux Pierre, Gardin Clau |
Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia. Leukemia & lymphoma 2017 8 59 (5): 1095-1104. Sanchez-Garcia Joaquin, Falantes Jose, Medina Perez Angeles, Hernandez-Mohedo Francisca, Hermosin Lourdes, Torres-Sabariego Angeles, Bailen Alicia, Hernandez-Sanchez Jesus M, Solé Rodriguez María, Casaño Francisco Javier, Calderon Cristina, Labrador Maria, Vahí Maria, Serrano Josefina, Lumbreras Eva, Hernández-Rivas Jesus Maria, |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 30, 2023
- Content source: